… sequelae following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
impairment. Objectives: The aim of this study was to identify and characterize pulmonary sequelae …

… after COVID-19 in large cohorts of patients with asthma is not yet available. The DLCO
impairment we observed in our patients with asthma might be related both to COVID-19 sequelae …

… and observed that DLno impairment exceeded DLco impairment, but both values were lower
… In conclusion, COVID-19 related pulmonary disease is associated with impaired diffusing …

… of lung function in discharged survivors with COVID-19 is impairment of diffusion capacity, …
impaired diffusion capacity. At 3-months after discharge, residual abnormalities of pulmonary …

… and consists of the long-COVID-19 syndrome. The aim of the … on the pulmonary manifestations
of the long COVID-19 … impairment may complicate the recovery course of COVID-19…

… The aim of this study was to investigate pulmonary impairments, as well as the prevalence
of other organ dysfunctions and psychological disorders in patients with COVID-19 six weeks …

… -up strategy for COVID-19 patients after clinical … impairment in a cohort of COVID-19 patients
after hospital discharge and to determine the relationship between the severity of pulmonary …

… In conclusion, our study reveals that, in discharged survivors with COVID-19, impairment
of diffusion capacity is the most common abnormality of lung function, followed by restrictive …

… of COVID-19 pneumonia on survivors’ pulmonary function and … the impact of COVID-19
pneumonia on pulmonary function, … of non-critical COVID-19 pneumonia survivors have impaired …

… Our study was a pilot study which first described the impaired pulmonary function in patients
with COVID-19 at time of discharge. Impairment of diffusion capacity is the most common …